Press Releases May 1, 2026 08:00 AM

Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference

Stryker to present at Bank of America Securities 2026 Global Healthcare Conference

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
SYK

Stryker Corporation announced its participation in the Bank of America Securities 2026 Global Healthcare Conference scheduled for May 13, 2026. The company will be represented by its President and COO, CFO for MedSurg and Neurotechnology, and VP of Investor Relations. A live webcast of the presentation will be available on Stryker's website.

Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
SYK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Stryker is participating in a major healthcare investor conference, indicating active engagement with investors.
  • Presentation will cover key business segments: MedSurg, Neurotechnology, and Orthopaedics.
  • The event offers a platform to communicate company strategy and performance directly to investors and analysts.

Portage, Michigan, May 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on Wednesday, May 13, 2026, at the Encore at Wynn Hotel in Las Vegas, Nevada.

Representing the company will be Spencer Stiles, President and Chief Operating Officer, Jason Beach, Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology and Nick Mead, Vice President, Investor Relations. Their presentation is scheduled for 1:40 p.m. Pacific Time.

A live webcast and replay of the presentation will be accessible on Stryker’s website at www.stryker.com, and it will be archived on the Investor Relations page.

About Stryker

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Contacts

For investor inquiries:
Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com

For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com


Risks

  • The article does not disclose new financial or operational data, so market reaction may be limited.
  • Investor expectations from the presentation may vary based on broader healthcare sector trends and competitive landscape.
  • Market reactions could be impacted by macroeconomic factors affecting healthcare stocks at the time of the conference.

More from Press Releases

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026